The pediatric metabolic syndrome.
J A Morrison1, E S Ford, J Steinberger
1Division of Cardiology, Children's Hospital Medical Center, Cincinnati, OH, USA.
Minerva Medica
|May 24, 2008
Summary
Metabolic syndrome, a cluster of conditions including obesity and high blood pressure, is linked to diabetes and heart disease. Its definition and validity remain debated among researchers.
Area of Science:
- Metabolic Syndrome Research
- Pediatric and Adult Health
- Cardiovascular Disease and Diabetes
Background:
- Metabolic syndrome is increasingly recognized due to its association with obesity, diabetes mellitus, and cardiovascular disease.
- The syndrome's definition is contentious, with multiple adult and pediatric definitions existing.
- Clustering of metabolic risk factors predicts type 2 diabetes and cardiovascular disease.
Purpose of the Study:
- To review the background and evolution of the metabolic syndrome concept.
- To explore the interrelationships among the components of metabolic syndrome.
- To discuss the ongoing debates and potential treatment strategies for metabolic syndrome.
Main Methods:
- Literature review of existing definitions and studies on metabolic syndrome.
- Analysis of long-term cohort studies and longitudinal data.
- Discussion of interrelationships between obesity, dyslipidemia, hypertension, impaired glucose metabolism, and acute phase reactants.
Main Results:
- Multiple definitions for adult and pediatric metabolic syndrome exist, causing definitional ambiguity.
- Long-term studies confirm that metabolic syndrome components predict type 2 diabetes and cardiovascular disease.
- Compromised vascular function is observed in young adults with metabolic syndrome.
Conclusions:
- Metabolic syndrome is a significant health concern with clear links to major chronic diseases.
- Despite definitional challenges, the predictive value of metabolic syndrome components is supported by longitudinal data.
- Further research and consensus on definitions and treatments are needed.
More Related Videos
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase (COX/SDH) Double-labeling Histochemistry
Published on: November 23, 2011
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...